Evidence map›Paper›PMID 25213556›Full record

ArticleCardiovascular research2015

Emergence of Orai3 activity during cardiac hypertrophy.

Youakim Saliba, Mathilde Keck, Alexandre Marchand, Fabrice Atassi, Aude Ouillé, Olivier Cazorla, Mohamed Trebak, Catherine Pavoine, Alain Lacampagne, Jean-Sébastien Hulot and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in Cardiovascular research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 42 citations in OpenAlex.

  1. Review
  2. The CaInternational journal of molecular sciences · 2026
    Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. SOCE in the cardiomyocyte: the secret is in the chambers.Pflugers Archiv : European journal of physiology · 2021
    Review
  14. Proteins Interacting with STIM1 and Store-Operated CaProgress in molecular and subcellular biology · 2021
    Review
  15. Article
  16. Article
  17. Article
  18. Targeting Orai1-Mediated Store-Operated CaFrontiers in cell and developmental biology · 2020
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 7 institutions in 3 countries.

Youakim SalibaSorbonne Universités, UPMC Univ Paris 06, UMR_S 1166, ICAN, F-75005 Paris, France INSERM, UMR_S 1166, ICAN, F-75005 Paris, France Laboratoire de Recherche en Physiologie et Physiopathologie, Pôle Technologie Santé, Faculté de Médecine, Université Saint Joseph, Beyrouth, Lebanon.
Mathilde KeckSorbonne Universités, UPMC Univ Paris 06, UMR_S 1166, ICAN, F-75005 Paris, France INSERM, UMR_S 1166, ICAN, F-75005 Paris, France.
Alexandre MarchandSorbonne Universités, UPMC Univ Paris 06, UMR_S 1166, ICAN, F-75005 Paris, France INSERM, UMR_S 1166, ICAN, F-75005 Paris, France.
Fabrice AtassiSorbonne Universités, UPMC Univ Paris 06, UMR_S 1166, ICAN, F-75005 Paris, France INSERM, UMR_S 1166, ICAN, F-75005 Paris, France.
Aude OuilléUniversité Montpellier 1 et 2, Inserm U1046, Montpellier, France.
Olivier CazorlaUniversité Montpellier 1 et 2, Inserm U1046, Montpellier, France.
Mohamed TrebakSUNY College of Nanoscale Science and Engineering, Albany, NY, USA.
Catherine PavoineSorbonne Universités, UPMC Univ Paris 06, UMR_S 1166, ICAN, F-75005 Paris, France INSERM, UMR_S 1166, ICAN, F-75005 Paris, France.
Alain LacampagneUniversité Montpellier 1 et 2, Inserm U1046, Montpellier, France.
Jean-Sébastien HulotSorbonne Universités, UPMC Univ Paris 06, UMR_S 1166, ICAN, F-75005 Paris, France INSERM, UMR_S 1166, ICAN, F-75005 Paris, France Cardiovascular Research Center, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Nassim FarèsLaboratoire de Recherche en Physiologie et Physiopathologie, Pôle Technologie Santé, Faculté de Médecine, Université Saint Joseph, Beyrouth, Lebanon.
Jérémy FauconnierUniversité Montpellier 1 et 2, Inserm U1046, Montpellier, France.
Anne-Marie LompréSorbonne Universités, UPMC Univ Paris 06, UMR_S 1166, ICAN, F-75005 Paris, France INSERM, UMR_S 1166, ICAN, F-75005 Paris, France anne-marie.lompre@upmc.fr.
Inserm · FRSorbonne Université · FRIcahn School of Medicine at Mount Sinai · USPurchase College · USSaint Joseph University · LBUniversité de Montpellier · FRUniversité Paris Cité · FR

Funding

Receptor-regulated Ca2+ Entry Pathways in Smooth MuscleR01HL097111 · NHLBI · STATE UNIVERSITY OF NEW YORK AT ALBANY · PI TREBAK, MOHAMED · 2010 to 2019
$3.7M
Role of STIM1 in cardiac hypertrophy and heart failureR01HL113497 · NHLBI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI AKAR, FADI GABRIEL · 2012 to 2016
$2.1M
Leukotriene C4 and STIM/Orai channels in airway smooth muscle remodelingR01HL123364 · NHLBI · STATE UNIVERSITY OF NEW YORK AT ALBANY · PI TREBAK, MOHAMED · 2014 to 2017
$1.5M
NHLBI NIH HHS R01HL097111NHLBI NIH HHS R01 HL113497NHLBI NIH HHS R01HL113497NHLBI NIH HHS R01 HL123364NHLBI NIH HHS R01HL123364
6 · The paper itself

Abstract

aimsStromal interaction molecule 1 (STIM1) has been shown to control a calcium (Ca(2+)) influx pathway that emerges during the hypertrophic remodelling of cardiomyocytes. Our aim was to determine the interaction of Orai1 and Orai3 with STIM1 and their role in the constitutive store-independent and the store-operated, STIM1-dependent, Ca(2+) influx in cardiomyocytes. METHODS AND

resultsWe characterized the expression profile of Orai proteins and their interaction with STIM1 in both normal and hypertrophied adult rat ventricular cardiomyocytes. Orai1 and 3 protein levels were unaltered during the hypertrophic process and both proteins co-immunoprecipitated with STIM1. The level of STIM1 and Orai1 were significantly greater in the macromolecular complex precipitated by the Orai3 antibody in hypertrophied cardiomyocytes. We then used a non-viral method to deliver Cy3-tagged siRNAs in vivo to adult ventricular cardiomyocytes and silence Orai channel candidates. Cardiomyocytes were subsequently isolated then the voltage-independent, i.e. store-independent and store-operated Ca(2+) entries were measured on Fura-2 AM loaded Cy3-labelled and control isolated cardiomyocytes. The whole cell patch-clamp technique was used to measure Orai-mediated currents. Specific Orai1 and Orai3 knockdown established Orai3, but not Orai1, as the critical partner of STIM1 carrying these voltage-independent Ca(2+) entries in the adult hypertrophied cardiomyocytes. Orai3 also drove an arachidonic acid-activated inward current.

conclusionCardiac Orai3 is the essential partner of STIM1 and drives voltage-independent Ca(2+) entries in adult cardiomyocytes. Arachidonic acid-activated currents, which are supported by Orai3, are present in adult cardiomyocytes and increased during hypertrophy.

Indexed as

AnimalsArachidonic AcidCalcium Channel AgonistsCalcium ChannelsCalcium SignalingCells, CulturedDisease Models, AnimalHypertrophy, Left VentricularMaleMembrane GlycoproteinsMembrane PotentialsMyocytes, CardiacORAI1 ProteinProtein BindingRats, WistarRNA InterferenceArachidonic AcidCalcium Channel AgonistsCalcium ChannelsMembrane GlycoproteinsORAI1 ProteinOrai1 protein, ratOrai3 protein, ratStim1 protein, ratStromal Interaction Molecule 1CalciumCardiac hypertrophyOraiSiRNASTIM1

Identifiers

PMID25213556
PMCPMC4351368
OpenAlexW2107324860

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.